Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The immunoregulatory role of lncRNA UCA1: a pan-cancer perspective with a focus on colorectal cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41071316 | PubTator, text mining | PubMed |
| Regulation of Cancer Stem Cells in the Tumor Microenvironment. | Cancer Heterog Plast | 2025 | 41868064 | PubTator, text mining | PubMed |
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
| Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient Cohort. | Pharmaceuticals (Basel) | 2025 | 41599670 | PubTator, text mining | PubMed |
| Innovations in Oncology Diagnostics: Genetic Research and Liquid Biopsy as Tools of Personalised Medicine. | Asian Pac J Cancer Prev | 2025 | 41459869 | PubTator, text mining | PubMed |
| Regulatory roles of non-coding and exosomal RNAs in colorectal cancer: spotlight on angiogenesis. | Clin Exp Med | 2025 | 41331186 | PubTator, text mining | PubMed |
| Dysregulated lncRNAs in Cisplatin-Induced Nephrotoxicity and Their Association with Apoptosis and Autophagy: An Exploratory In Vitro Study. | Int J Mol Sci | 2025 | 41303683 | PubTator, text mining | PubMed |
| The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer. | Int J Mol Sci | 2025 | 41303609 | PubTator, text mining | PubMed |
| SARS-CoV-2 reshapes m6A methylation in long noncoding RNAs of human lung cells. | NAR Mol Med | 2025 | 41267684 | PubTator, text mining | PubMed |
| Comparison of Long Non-Coding RNA Expressions in Endometrial Polyp and Endometrial Cancer Cases. | Diagnostics (Basel) | 2025 | 41226033 | PubTator, text mining | PubMed |
| Correction to "LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14". | J Oncol | 2025 | 41216391 | PubTator, text mining | PubMed |
| Study on the up-regulated lncRNA UCA1 as prognostic biomarker of severe pneumonia and its possible regulatory mechanism. | Biomark Med | 2025 | 41201026 | PubTator, text mining | PubMed |
| Retraction Statement: Long non-coding RNA UCA1 relieves cardiomyocytes H9c2 injury aroused by oxygen-glucose deprivation via declining miR-12. | Artif Cells Nanomed Biotechnol | 2025 | 41134720 | PubTator, text mining | PubMed |
| Retraction Statement: Long non-coding RNA UCA1 exerts growth modulation by miR-15a in human thyroid cancer TPC-1 cells. | Artif Cells Nanomed Biotechnol | 2025 | 41134712 | PubTator, text mining | PubMed |
| Therapeutic potential of hAMSCs in ligament regeneration: insights from the UCA1-miR-16-5p-FGF2 pathway. | Stem Cell Res Ther | 2025 | 41074069 | PubTator, text mining | PubMed |
| Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer. | BMC Cancer | 2025 | 41068676 | PubTator, text mining | PubMed |
| Restoring Tamoxifen Sensitivity in Breast Cancer: The Role of lncRNA MALAT1 and NanoCurcumin as Modulators of Drug Resistance. | Biomed Res Int | 2025 | 41031251 | PubTator, text mining | PubMed |
| LncRNA B4GALT 1-AS1/miR-144-3p axis suppresses cytotoxicity of CD8+ T cells in lung adenocarcinoma by modulating PD-L1 expression. | Discov Oncol | 2025 | 41003936 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| Integrating BERT pre-training with graph common neighbours for predicting ceRNA interactions. | Front Genet | 2025 | 40969328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=3